Latest Johnson & Johnson Stories
- DECN POINTS TO HIGH RISK GAMBLE IN J&J's RASH ATTEMPT TO MITIGATE TOTALITY OF LOSS IN PATENT LITIGATION LOS ANGELES, April 21, 2015 /PRNewswire/ -- Decision Diagnostics Corp.
NEW BRUNSWICK, N.J., April 20, 2015 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a review of its Pharmaceutical business for the investment community beginning at 8:30 a.m.
Bernstein Liebhard LLP is representing hundreds of clients who have filed Depuy Pinnacle lawsuits in the federal multidistrict litigation underway in the Northern District of Texas.
Trial is the first to study schizophrenia treatment within the context of many real-world issues faced by patients with schizophrenia TITUSVILLE, N.J., April 15, 2015 /PRNewswire/ -- A study
Bernstein Liebhard LLP is representing numerous clients in the DePuy ASR hip recall litigation, all of whom allegedly experienced chronic pain, metallosis, premature device failure and other debilitating
Presentations include late-breaking final results from the Phase 3 OPTIMIST trials and interim results from the Phase 2 IMPACT trial of simeprevir CORK, Ireland, April 8, 2015 /PRNewswire/
GIA announces the release of a comprehensive global report update on Surgical Incision Closures.
Bernstein Liebhard LLP is representing hundreds of women who have filed vaginal mesh lawsuits against Ethicon, Inc. and Boston Scientific Corp.
Surgeons Have New Solution for Controlling Problematic Bleeding Situations During Adult Liver Surgery SOMERVILLE, N.J., April 6, 2015 /PRNewswire/ -- Unexpected and uncontrollable
Bernstein Liebhard LLP is representing numerous women who have filed tranvaginal mesh lawsuits in New Jersey Superior Court, all of whom allegedly suffered serious complications following implantation